Drugs / SCH 497079
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 missed | ||||||
| Phase 1 | NCT00673465 | Apr → Dec 2008 | type 2 diabetes mellitus | Merck Sharp & Dohme LLC | Completed | Missed primary |
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT00642993 | Jun 2008 → Jan 2009 | obesity disorder | Merck Sharp & Dohme LLC | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCH 497079 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00642993 ↗ |
| Route | Oral | “administered orally” NCT00642993 ↗ |